Top 50 Opportunities for Generic Pharmaceutical Companies Assessed in…

New research study “Prioritizing Generic Drug development pipeline – The top Fifty Opportunities” developed by MP Advisors has been recently published by Market Publishers Ltd.

(PRWeb August 20, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!